{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:51:04Z","timestamp":1774122664088,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Radiation Research Program"},{"name":"Small Business Innovation Research Development Center"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ijrobp.2018.12.027","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:48:54Z","timestamp":1545421734000},"page":"188-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts"],"prefix":"10.1016","volume":"104","author":[{"given":"Kaveh","family":"Zakeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhadrasain","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Norman","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pataje G.S.","family":"Prasanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.12.027_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jnci\/95.9.646","article-title":"Development of investigational radiation modifiers","volume":"95","author":"Colevas","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib2","doi-asserted-by":"crossref","first-page":"173sr2","DOI":"10.1126\/scitranslmed.3005148","article-title":"New paradigms and future challenges in radiation oncology: An update of biological targets and technology","volume":"5","author":"Liauw","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1667\/RR14186.1","article-title":"Radioprotectors and radiomitigators for improving radiation therapy: The Small Business Innovation Research (SBIR) gateway for accelerating clinical translation","volume":"184","author":"Prasanna","year":"2015","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib4","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0959-8049(16)32770-8","article-title":"Antitumor and anti-inflammatory effects of the sphingosine kinase-2 inhibitor ABC294640 in combination with radiation","volume":"69","author":"Smith","year":"2016","journal-title":"Eur J Cancer"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2018.12.027_bib5","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1016\/S0016-5085(16)31693-6","article-title":"Su1194 novel therapeutic for the repair of gastrointestinal radiation injury","volume":"150","author":"Townsend","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2011.05.055","article-title":"Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: Implications for head-and-neck cancer radiotherapy","volume":"83","author":"Burdelya","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1667\/RR14514.1","article-title":"Mitigation of radiation-induced epithelial damage by the TLR5 agonist entolimod in a mouse model of fractionated head and neck irradiation","volume":"187","author":"Toshkov","year":"2017","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib8","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/S1525-0016(16)35673-8","article-title":"Manganese superoxide dismutase plasmid liposomes (MnSOD-PL) protects the murine oral cavity from irradiation induced mucositis","volume":"22","author":"Shinde","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/1091581816642766","article-title":"Nonclinical safety and toxicokinetics of MnTnBuOE-2-PyP5+ (BMX-001)","volume":"35","author":"Gad","year":"2016","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5099\/aj140300157","article-title":"UTL-5g lowers levels of TGF-\u03b2 and TNF-\u03b1 elevated by lung irradiation and does not affect tumor-response to irradiation","volume":"6","author":"Brown","year":"2014","journal-title":"Am J Biomed Sci"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib11","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1111\/bph.14056","article-title":"BIO 300, a nanosuspension of genistein, mitigates pneumonitis\/fibrosis following high-dose radiation exposure in the C57L\/J murine model","volume":"174","author":"Jackson","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1667\/RR14409.1","article-title":"Nuclear countermeasure activity of tp508 linked to restoration of endothelial function and acceleration of DNA repair","volume":"186","author":"Olszewska-Pazdrak","year":"2016","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR14784.1","article-title":"Radiation-induced fibrosis: Mechanisms and opportunities to mitigate. Report of an NCI Workshop, September 19, 2016","volume":"188","author":"Citrin","year":"2017","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib14","author":"Puthenedam"},{"issue":"suppl 15","key":"10.1016\/j.ijrobp.2018.12.027_bib15","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/jco.2015.33.15_suppl.3063","article-title":"A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers","volume":"33","author":"Bakhribah","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.12.027_bib16","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-16-2363","article-title":"A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors","volume":"23","author":"Britten","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618341932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618341932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T16:24:25Z","timestamp":1573489465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618341932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0360301618341932"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.12.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}